Theratechnologies Receives Positive Recommendation from the CHMP for Trogarzo® in the European Union

Jul 26, 2019
PDF Version
Supporting Materials:
Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the Committee for Medicinal Products for Human use (CHMP) in Europe has given a positive recommendation for the approval of Trogarzo® (ibalizumab) for the treatment of Multidrug Resistant HIV-1.